The role of uric acid in the pathogenesis of human cardiovascular disease

被引:428
作者
Kanbay, Mehmet [1 ]
Segal, Mark [2 ]
Afsar, Baris [3 ]
Kang, Duk-Hee [4 ]
Rodriguez-Iturbe, Bernardo [5 ]
Johnson, Richard J. [6 ]
机构
[1] Medeniyet Univ, Sch Med, Dept Med, Div Nephrol, TR-03460 Istanbul, Turkey
[2] Univ Florida, Div Nephrol, Gainesville, FL USA
[3] Konya Numune State Hosp, Dept Med, Div Nephrol, Konya, Turkey
[4] Ewha Womans Univ, Sch Med, Ewha Med Res Ctr, Dept Internal Med,Div Nephrol, Seoul, South Korea
[5] Univ Hosp, Renal Serv, Maracaibo, Venezuela
[6] Univ Colorado, Div Nephrol, Denver, CO 80202 USA
关键词
IMPROVES ENDOTHELIAL FUNCTION; CORONARY-HEART-DISEASE; MUSCLE-CELL-PROLIFERATION; XANTHINE-OXIDASE INHIBITION; RENIN-ANGIOTENSIN SYSTEM; OXIDATIVE STRESS; BLOOD-PRESSURE; NITRIC-OXIDE; SERUM URATE; RISK-FACTOR;
D O I
10.1136/heartjnl-2012-302535
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Hyperuricaemia is common in subjects with cardiovascular disease, but is not commonly considered a true risk factor. Recent studies suggest that uric acid is biologically active and can stimulate oxidative stress, endothelial dysfunction, inflammation and vasoconstriction. Epidemiological studies have found that uric acid can independently predict the development of hypertension, as well as stroke and heart failure. Experimentally raising uric acid in animals increases blood pressure, and pilot studies suggest that lowering uric acid in humans can reduce blood pressure in hypertensive individuals. Uric acid may also have emerging roles in the pathogenesis of kidney disease, metabolic syndrome and diabetes. More studies need to be performed on the pathophysiology and clinical consequences of hyperuricaemia in cardiovascular disease.
引用
收藏
页码:759 / 766
页数:8
相关论文
共 139 条
[1]
Serum uric acid and cardiovascular events in successfully treated hypertensive patients [J].
Alderman, MH ;
Cohen, H ;
Madhavan, S ;
Kivlighn, S .
HYPERTENSION, 1999, 34 (01) :144-150
[2]
URIC-ACID PROVIDES AN ANTIOXIDANT DEFENSE IN HUMANS AGAINST OXIDANT-CAUSED AND RADICAL-CAUSED AGING AND CANCER - A HYPOTHESIS [J].
AMES, BN ;
CATHCART, R ;
SCHWIERS, E ;
HOCHSTEIN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (11) :6858-6862
[3]
[Anonymous], THE FAT SWITCH
[4]
Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki [J].
Baba, Takeshi ;
Amasaki, Yasuko ;
Soda, Midori ;
Hida, Ayumi ;
Imaizumi, Misa ;
Ichimaru, Shinichiro ;
Nakashima, Eiji ;
Setu, Shinji ;
Yano, Katsusuke ;
Akahoshi, Masazumi .
HYPERTENSION RESEARCH, 2007, 30 (09) :823-829
[5]
Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications [J].
Berry, CE ;
Hare, JM .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (03) :589-606
[6]
Uric acid is a risk factor for myocardial infarction and stroke - The Rotterdam Study [J].
Bos, Michiel J. ;
Koudstaal, Peter J. ;
Hofman, Albert ;
Witteman, Jacqueline C. M. ;
Breteler, Monique M. B. .
STROKE, 2006, 37 (06) :1503-1507
[7]
Xanthine oxidoreductase in respiratory and cardiovascular disorders [J].
Boueiz, Adel ;
Damarla, Mahendra ;
Hassoun, Paul M. .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 294 (05) :L830-L840
[8]
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension [J].
Butler, R ;
Morris, AD ;
Belch, JJF ;
Hill, A ;
Struthers, AD .
HYPERTENSION, 2000, 35 (03) :746-751
[9]
HYPERURICEMIA IN PRIMARY AND RENAL HYPERTENSION [J].
CANNON, PJ ;
STASON, WB ;
DEMARTINI, FE ;
SOMMERS, SC ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1966, 275 (09) :457-+
[10]
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy [J].
Cappola, TP ;
Kass, DA ;
Nelson, GS ;
Berger, RD ;
Rosas, GO ;
Kobeissi, ZA ;
Marbán, E ;
Hare, JM .
CIRCULATION, 2001, 104 (20) :2407-2411